Below is a daily summary of links to the latest SPAC news and rumors gathered across the web.
Latest SPAC News: AlTi Global buys Singapore wealth firm AL Wealth Partners and YS Biopharma’s PIKA rabies vaccine receives phase 3 clinical trial approval
Alti Global Buys Singapore Wealth Firm For Asia Expansion
AlTi Global Inc. (NASDAQ:ALTI) has agreed to buy Singaporean money manager AL Wealth Partners, joining the rush of firms tapping the rapid rise of wealthy families in the city-state and across Southeast Asia.
AlTi was formed in January through a SPAC deal that combined Alvarium Investments and Tiedemann Wealth Management Holdings. The company had about $65 billion in assets under management or advisory as of December.
READYS Biopharma’s PIKA Rabies Vaccine Receives Phase 3 Clinical Trial Approval in Pakistan
YS Biopharma Co., Ltd. (NASDAQ: YS), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and commercializing new generations of vaccines and therapeutic biologics for infectious diseases and cancer, today announced its PIKA Rabies Vaccine has received Phase 3 clinical trial approval from the Drug Regulatory Authority of Pakistan (“DRAP”). The Phase 3 clinical trial will evaluate the safety and immunogenicity of the Company’s PIKA Rabies Vaccine in preventing rabies infection.
YS Biopharma completed its business combination with Summit Healthcare in March.
READ


Cayson Acquisition Corp. (NASDAQ:CAPN) has entered into a definitive agreement to combine with boutique investment firm Mango Financial for $300 million in equity consideration. Hong Kong-based Mango provides a range of M&A and equity capital markets advisory services to clients considering listings in China and the US. The combined company is expected to trade on...
Trailblazer (NASDAQ:BLZRU) has filed for a $200 million SPAC to bring a first-time team to market with serial sponsor terms. The new SPAC is offering investors a 1/3 warrant in each unit and it is the first SPAC filed so far this month with 24 months on its initial transaction clock. All other July SPACs...
This week, we speak with Kyivstar CEO Oleksandr Komarov about the company’s $2.2 billion dollar combination with Cohen Circle Acquisition Corp. I (NASDAQ:CCIR). Few companies have been had to forge themselves in the flames recently quite like Ukraine’s leading telecom and digital services provider Kyivstar. Now, Kyivstar is not only telling that story but pitching it to...
At the SPAC of Dawn The market still has one full trading session before it adds Tuesday’s Core CPI reading and a variety of Fed comments to messaging it is already ingesting on US President Donald Trump’s ever-shifting tariff policy. SPACs are meanwhile continuing on with business as usual, with Cayson (NASDAQ:CAPN) announcing the third...
Terms Tracker for the Week Ending July 11, 2025 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. One more IPO priced this week bringing July’s total to 8. However, there are still three more weeks left in the month so that number...